MINI FUTURE LONG - COOPER COMPANIES Stock

Certificat

DE000MG06H70

Real-time Bid/Ask 07:34:35 2024-07-16 am EDT
0.29 EUR / 0.3 EUR +5.36% Intraday chart for MINI FUTURE LONG - COOPER COMPANIES
1 month-17.65%
3 months-17.65%
Date Price Change
24-07-16 0.29 +3.57%
24-07-15 0.28 -6.67%
24-07-12 0.3 +7.14%
24-07-11 0.28 +7.69%
24-07-10 0.26 0.00%

Delayed Quote Börse Stuttgart

Last update July 16, 2024 at 03:15 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG06H7
ISINDE000MG06H70
Date issued 2024-03-13
Strike 57.48 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.44
Lowest since issue 0.25
Spread 0.01
Spread %3.33%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
88.67 USD
Average target price
110.8 USD
Spread / Average Target
+25.01%
Consensus